Survey 38 - PERCEPTION ON PROBIOTICS IN CHILDRENMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Multicentre retrospective clinical chronicle on the use of probiotics in infantile colicSection 1: Clinical Presentation and Prevalence1. In your clinical practice, what is the average daily volume of infantile colic cases you encounter? Less than 5 cases 5–10 cases 10–20 cases More than 20 cases2. Which clinical criterion do you primarily use to diagnose infantile colic in your practice? Wessel’s Criteria (Rule of Three) Rome IV Criteria Parental report of inconsolable crying only Modified criteria based on Indian dietary/cultural habits3. At what age do you typically observe the peak intensity of colic symptoms in Indian infants? 0–2 weeks 3–6 weeks 7–12 weeks Beyond 3 monthsSection 2: Management Strategies and Probiotic Adoption4. What is your first-line approach for managing uncomplicated infantile colic? Parental counseling and reassurance only Dietary modifications (Maternal diet/Formula change) Pharmacological intervention (Simethicone/Dicyclomine) Early initiation of targeted probiotics (e.g., BB-12)5. How frequently do you prescribe probiotics as a primary or adjunctive therapy for colic? Always (>90% of cases) Often (50–90% of cases) Occasionally (10–50% of cases) Rarely (<10% of cases)6. When selecting a probiotic, how important is "Strain Specificity" (e.g., BB-12 vs. generic Bifidobacterium) to your clinical decision? Critically important (Evidence-based choice) Moderately important Slightly important Not important (I prescribe by brand/availability)Section 3: Focus on Bifidobacterium animalis subsp. lactis BB-127. Based on your retrospective observation, what is the typical onset of action for BB-12 in reducing daily crying time? Within 3 days 4–7 days 8–14 days More than 2 weeks8. In your experience, what is the primary clinical benefit of using BB-12 in colicky infants? Reduction in total duration of crying/fussing Improved stool consistency and frequency Reduction in perceived abdominal gas/distension Improved sleep quality for both infant and parents9. What is your preferred duration of BB-12 supplementation for sustained relief from colic symptoms? 7 days 14 days 21–28 days Until symptoms completely resolve10. How would you rate the efficacy of BB-12 in breastfed vs. formula-fed Indian infants? Significantly more effective in breastfed infants Significantly more effective in formula-fed infants Equally effective in both groups Inconclusive based on current observationsSection 4: Safety, Compliance, and Outcomes11. Which dosage form of BB-12 do you find leads to the highest parental compliance in the Indian demographic? Oil-based drops Aqueous-based drops Sachet/Powder mixed with feeds All have similar compliance12. In your retrospective review, have you observed any significant adverse events associated with BB-12 administration? None (Excellent safety profile) Mild constipation/diarrhea Increased spit-up/regurgitation Skin rashes13. What percentage of patients show a ≥50% reduction in crying time within 2 weeks of using BB-12? More than 80% of patients 60–80% of patients 40–60% of patients Less than 40% of patients14. Beyond colic, what secondary benefit do you most frequently observe with BB-12 use? Reduced incidence of respiratory infections Improved weight gain Prevention of antibiotic-associated diarrhea (AAD) Faster resolution of neonatal jaundice15. How likely are you to recommend BB-12 as the "Gold Standard" probiotic for infantile colic management based on your clinical experience? Highly Likely Likely Neutral Unlikely I have read and agree to the Terms and Conditions .Submit Form